Pharmaceutically acceptable salts of indole derivatives useful for the treatment of inflammatory disorders

Abstract

The invention provides a pharmaceutically acceptable salt of a compound which is selected from the group consisting of: 3-{4-[(2-{5-chloro-1-(diphenylmethyl)-2-[2-({[2-(trifluoromethyl) benzyl] sulfonyl} amino) ethyl]-1H-indol-3-yl} ethyl) sulfonyl] phenyl} propanoic acid and 4-(3-{5-chloro-1-(diphenylmethyl)-2-[2-({[2-(trifluoromethyl) benzyl] sulfonyl} amino)ethyl]-1H-indo1-3-yl}propyl) benzoic acid. The salts are indicated for the treatment of inflammatory disorders, including asthma.